| 56626-5 |
Tetrachloroethylene |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Tetrachloroethylene [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
56626-5 |
|
|
|
|
Both |
|
|
|
0 |
TTCE Bld-sCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Perchloroethylene; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tetrachloroethene; TTCE; WB; Whole blood |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 56627-3 |
Procollagen type III |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Procollagen type III [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
56627-3 |
|
|
|
|
Both |
|
|
|
0 |
Procollagen III Ser-mCnc |
|
|
|
N |
|
3; Chemistry; Level; Mass concentration; Point in time; Procollagen III; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.7 |
2.29 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 56628-1 |
Amikacin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Amikacin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
56628-1 |
|
|
|
|
Both |
|
|
|
0 |
Amikacin SerPl-sCnc |
|
|
|
N |
|
Amikin; Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
2.29 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 56629-9 |
Myelin Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Myelin Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56629-9 |
|
IF |
|
|
Both |
|
|
|
0 |
Myelin Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 5663-0 |
Heavy metals positive |
Prid |
Urine |
Pt |
Nom |
Screen |
|
ACTIVE |
Heavy metals positive [Identifier] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
5663-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Heavy Metals Pos Ur Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Heavy met; Identity or presence; Metal; Nominal; Point in time; Pos; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 56630-7 |
Brucella sp Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
56630-7 |
|
IA |
|
|
Both |
|
|
|
0 |
Brucella IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS |
2.69 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56631-5 |
Brucella sp Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
56631-5 |
|
IA |
|
|
Both |
|
|
|
0 |
Brucella IgM Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS |
2.69 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56632-3 |
Mitochondria M2 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56632-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Mitochondria M2 IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; AMA-M2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Liver; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Point in time; Pyruvate dehydrogenase ab; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 56633-1 |
Myocardium Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Myocardium IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56633-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Myocardium IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antimyocardial; Antisarcolemma; Autoantibodies; Autoantibody; Cardio; Cardiology; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Heart; Heart Disease; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Intermyofibrillar Antibodies; Myocardial; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 56634-9 |
Nuclear Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
56634-9 |
|
IF |
|
|
Both |
|
|
|
0 |
Nuclear IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 56635-6 |
Thyroglobulin Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Thyroglobulin IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56635-6 |
|
|
|
|
Both |
|
|
|
0 |
Thyroglob IgG Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Hashimoto's thyroiditis; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker |
2.73 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 56636-4 |
Bordetella parapertussis Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
56636-4 |
|
IF |
|
|
Both |
|
|
|
0 |
B parapert IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B parapert; B parapertussis; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Whooping cough |
2.75 |
2.29 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 56637-2 |
Mi-2 Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Mi-2 Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56637-2 |
|
IA |
|
|
Both |
|
|
|
0 |
MI2 Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CHD2; Chromodomain-helicase-DNA-binding protein 2; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; MEIA; MI2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.69 |
2.29 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 56638-0 |
Rheumatoid arthritis nuclear Ab |
Titr |
Ser |
Pt |
Ord |
IF |
|
DEPRECATED |
Deprecated Rheumatoid arthritis nuclear Ab [Titer] in Serum Qualitative by Immunofluorescence |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
56638-0 |
|
IF |
|
|
Both |
|
|
|
0 |
Deprecated RA Nuc Ab Titr Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Arth; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MDAS; Multi-biomarker disease activity score; NA; Nuc; Ordinal; Point in time; QL; Qual; Qualitative; RA; RA Nuc; RANA; Random; Rheum; Rheumatology; Screen; Serology; Serum; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.36 |
2.29 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 56639-8 |
Methyl ethyl ketone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Methyl ethyl ketone [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
56639-8 |
|
|
|
|
Both |
|
|
|
0 |
MEK Ur-sCnc |
|
|
|
N |
|
2-Butanone; 3-butanone; Butanone; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Level; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 5664-8 |
Heavy metals negative |
Prid |
Urine |
Pt |
Nom |
Screen |
|
ACTIVE |
Heavy metals negative [Identifier] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
5664-8 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Heavy Metals Neg Ur Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Heavy met; Identity or presence; Metal; NEG; Nominal; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 56640-6 |
Aspartate/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Aspartate/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56640-6 |
|
|
|
|
Both |
|
|
|
0 |
Aspartate/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Asp; Aspartic acid; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56641-4 |
Threonine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Threonine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56641-4 |
|
|
|
|
Both |
|
|
|
0 |
Threonine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Thr; UA; UCr; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56642-2 |
Serine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Serine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56642-2 |
|
|
|
|
Both |
|
|
|
0 |
Serine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Ser; UA; UCr; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56643-0 |
Asparagine/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Asparagine/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56643-0 |
|
|
|
|
Both |
|
|
|
0 |
Asparagine/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Asn; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56644-8 |
Glutamate/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Glutamate/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56644-8 |
|
|
|
|
Both |
|
|
|
0 |
Glutamate/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; c707; Chemistry; CR; Crea; Creat; Glu; Glutamic acid; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.42 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56645-5 |
Vanillylmandelate/Creatine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Vanillylmandelate/Creatine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
CHEM |
|
56645-5 |
|
|
|
|
Both |
|
|
|
0 |
VMA/Creatine 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; 3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; QNT; Quan; Quant; Quantitative; Ratios; Rto; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56646-3 |
Trichloroacetate/Creatinine |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Trichloroacetate/Creatinine [Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
56646-3 |
|
|
|
|
Both |
|
|
|
0 |
TCA/Creat Ur-Rto |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; TCA; Trichloroacetic acid; UA; UCr; UR; Urn |
2.73 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56647-1 |
Phenol/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Phenol/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
56647-1 |
|
|
|
|
Both |
|
|
|
0 |
Phenol/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Oxybenzene; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
| 56648-9 |
Phenylglyoxylate/Creatinine |
Ratio |
Urine |
24H |
Qn |
|
|
ACTIVE |
Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
56648-9 |
|
|
|
|
Both |
|
|
|
0 |
Phenylglyoxylate/Creat 24h Ur-Rto |
|
|
|
N |
|
1 day; 24 hours; 24HR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Phenylglyoxylic acid; PhGA; QNT; Quan; Quant; Quantitative; Ratios; Rto; Styrene metabolite; UA; UCr; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
umol/g{creat} |
|
|
|
0 |
